Confirmed Speakers

 

  • Chris Bailey-Kellogg, Ph.D., Professor, Computer Science, University of Dartmouth
  • Frank Bernhard, Ph.D., Lab Manager, Biophysical Chemistry, Goethe University Frankfurt
  • Guoqing Cao, Ph.D., Vice President, Jiangsu Hengrui Medicine
  • Ying Ying Chan, Ph.D., Sales Manager, APAC Division, IntelliCyt, a Sartorius Company
  • Tse-wen Chang, Ph.D., President & CEO, Immunwork, Inc.
  • Bo Chen, Ph.D., CEO, Shanghai Junshi
  • Danny Chou, Ph.D., President, Compassion BioSolutions, LLC
  • Shan Chung, Ph.D., Senior Scientist and Group Leader, Bioanalytical Sciences, Genentech
  • Gael Debauve, Ph.D., Associate Director, Bioassay Development, UCB
  • Liangpeng Ge, Ph.D., Director, Institute of Bingengineering, Chongqing Academy of Animal Sciences
  • John C. Gebler, Ph.D., Director, Biopharma Business Development, Waters Corporation
  • Jinming Gu, Ph.D., Executive Director, Biologics Discovery, Shanghai Hengrui Pharmaceutical Co., Ltd.
  • Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health
  • Lucas Huang, Field Application Scientist, Unchained Labs
  • Yi Huang, Ph. D., Senior Manager of SCD, Biologics, USP-Chin
  • Chan Hyuk Kim, Ph.D., Assistant Professor, Biological Sciences, KAIST
  • Andrea Ji, Ph.D., Senior Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.
  • Tomasz Klaus, MSc., Research Assistant, Malopolska Centre of Biotechnology, Jagiellonian University in Krakow
  • Manfred Konrad, Ph.D., Max-Planck Institute for Biophysical Chemistry, Head, Enzyme Biochemistry Laboratory
  • Veronique Lecault, Ph.D., Co-Founder, AbCellera
  • Sunbae Lee, Ph.D., Senior Research Scientist, R&D Center, Alteogen, Inc.
  • Ming Lei, Senior Research Investigator II, Lead Discovery and Optimization, Bristol-Myers Squibb Company
  • Han Li, Ph.D., Principal Scientist, Leads Discovery & Optimization, Bristol-Myers Squibb Company
  • Kang Li, Ph.D., Head, Biologics, BeiGene, Ltd.
  • Zhuo Li, Ph.D., Application Specialist, NanoTemper Technologies
  • Qingcong Lin, Ph.D., Vice President, Shenogen Pharma Group
  • Bertil Lindmark, MD., Ph.D., Chief Medical Officer, ASLAN Pharmaceuticals
  • Hongtao Lu, Ph.D., Executive Vice President & CSO, Discovery, Zai Laboratory
  • Yanmei Lu, Ph.D., Scientist, Biochemical and Cellular Pharmacology, Genentech, Inc.
  • Jennifer McManus, Ph.D., Lecturer, Department of Chemistry, National University of Ireland Maynooth
  • Tatyana Mezhebovsky, Ph.D., Principal Scientist, BioFormulations, Sanofi US
  • Guangliang Greg Pan, Ph.D., Vice President, Technical Operations/CMC, MabSpace Biosciences (Suzhou) Co., Ltd.
  • Ravish Patel, Ph.D., Scientist, Bioanalytical (Biologics), Analytical Development Lab, EPR Centre for Cancer Research and Bioinformatics Pvt. Ltd. (A Vitane Group of Companies)
  • Xueming Qian, Ph.D., Chairman & CEO, MabSpace Biosciences
  • JianPing Qiu, Ph.D., Executive Vice President, YZY Biotherapeutics
  • Zhihua Julia Qiu, Ph.D., Vice President, R&D, Qyuns Therapeutics, Inc.
  • Frederic Rousseau, Ph.D., Professor and Principal Investigator, Cellular and Molecular Medicine, VIB Switch Lab/University of Leuven
  • Christian Schoeneich, Ph.D., Professor and Chair, Pharmaceutical Chemistry, University of Kansas Lawrence
  • Michael Schwenkert, Ph.D., Technical Sales Manager, Custom Antibodies, Sales, AbD Serotec, a Bio-Rad Company
  • Joost Schymkowitz, Ph.D., Professor and Principal Investigator, Cellular and Molecular Medicine, VIB Switch Lab/University of Leuven
  • Baozhen Shan, Ph.D., CEO, CSO, Bioinformatics Solutions, Inc.
  • Jamshid Tanha, Ph.D., Senior Research Officer, Human Health Therapeutics Portfolio, National Research Council Canada
  • Susumu Uchiyama, Ph.D., Associate Professor, Graduate School of Engineering, Osaka University
  • Jieyi Wang, Ph.D., CEO, Lyvgen Biopharma
  • Weili Wang, Ph.D., Director, Cell Culture, MaxCyte
  • Chengbin Wu, Ph.D., CEO, Epima
  • Timothy Xia, Vice President, Protein Sciences, GenScript USA Inc.
  • Ting Xu, Ph.D., CEO & President, Alphamab
  • Mark Yang Ph.D., Director of Fill Finish Development, BioPharmaceutical Development, Genzyme
  • Jifeng Zhang, Ph.D., Senior Director, Global Head of Device-ability, Global Biotherapeutics, Sanofi US
  • Ming Qiang Zhang, Ph.D., Head, R&D, Amgen Asia
  • Aichi Zhao, Ph.D., President, R&D, OriMabs, Ltd.
  • Lei Zheng, Ph.D., Assistant Professor, Oncology and Gastrointestinal Cancer, Johns Hopkins University
  • Eunice Zhou, Ph.D., Associate Adjunct Professor, Anesthesia, UC San Francisco
  • Joy Zhou, Ph.D., Principal Scientist / Associate Director, DP MST, Shire
  • Xiangyang Zhu, Ph.D., CEO, Huabo Biopharma (Shanghai) Co., Ltd.
  • Zhenping Zhu, Ph.D., Executive Vice President, Global Biologics R&D, Kadmon Corp, LLC

 

 

 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Register Today!

 

Download 2017 Brochure
Download 2017 Brochure

 

Premier Sponsors

 

Bioinformatics Soultions Inc

 

Unchained Labs 

 

Corporate Sponsors

AbCellera

 

Bio-Rad


Cold Spring Biotech Corp

GenScript CRO Logo

 

IntelliCyt_Sartorius

 

MaxCyte no tagline

 

Nanotemper Technologies  

 

 Waters_Black_with_tagline  

 


View All Sponsors

View All Media Partners

Promote your company’s latest technology and/or solution at PEGS CHINA. A limited number of agenda presentations (as part of a sponsorship package), exhibit space, branding, and promotional opportunities are available.

Celebrating 25 Years


Track 1

Protein & Antibody Engineering

Track 2

Protein Aggregation & Stability

Track 3

Immuno-Oncology

Track 4

Analytical Characterization of Biotherapeutics